OPKO Health, Inc. Contract with Customer, Performance Obligation Satisfied in Previous Period
OPKO Health, Inc. (OPK) reported Contract with Customer, Performance Obligation Satisfied in Previous Period of $100.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Notes
us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod · last filed 2026-08-28
- OPKO Health, Inc. contract with customer, performance obligation satisfied in previous period for the quarter ending 2026-06-30 was -$900.00K.
- OPKO Health, Inc. contract with customer, performance obligation satisfied in previous period for the quarter ending 2026-03-31 was $1.00M, a 33.33% decline year-over-year.
- OPKO Health, Inc. contract with customer, performance obligation satisfied in previous period for the quarter ending 2025-12-31 was $0.00.
- OPKO Health, Inc. contract with customer, performance obligation satisfied in previous period for the quarter ending 2025-09-30 was $600.00K, a 53.85% decline year-over-year.
- OPKO Health, Inc. contract with customer, performance obligation satisfied in previous period for fiscal 2025 was $1.30M, a 13.33% decline from fiscal 2024.
- OPKO Health, Inc. contract with customer, performance obligation satisfied in previous period for fiscal 2024 was $1.50M, a 92.19% decline from fiscal 2023.
- OPKO Health, Inc. contract with customer, performance obligation satisfied in previous period for fiscal 2023 was $19.20M, a 10.70% decline from fiscal 2022.
- OPKO Health, Inc. contract with customer, performance obligation satisfied in previous period for fiscal 2022 was $21.50M, a 46.78% decline from fiscal 2021.
| Period end | Contract with Customer, Performance Obligation Satisfied in Previous Period 3 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 3 month as first filed | Contract with Customer, Performance Obligation Satisfied in Previous Period 6 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 6 month as first filed | Contract with Customer, Performance Obligation Satisfied in Previous Period 9 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$900.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $100.00K 10-Q/A · filed 2026-08-28 | $100.00K derived: sum of 3 quarters · filed 2026-08-28 | $700.00K derived: sum of 4 quarters · filed 2026-08-28 | ||
| 2026-03-31 | $1.00M 10-Q/A · filed 2026-08-28 | $1.00M derived: sum of 2 quarters · filed 2026-08-28 | $1.60M derived: sum of 3 quarters · filed 2026-08-28 | $800.00K derived: sum of 4 quarters · filed 2026-08-28 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $600.00K derived: sum of 2 quarters · filed 2026-02-26 | -$200.00K derived: sum of 3 quarters · filed 2026-08-28 | $1.30M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $600.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | -$200.00K derived: sum of 2 quarters · filed 2026-08-28 | $1.30M 10-Q · filed 2025-10-29 | $600.00K derived: sum of 4 quarters · filed 2026-08-28 | ||
| 2025-06-30 | -$800.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $700.00K 10-Q/A · filed 2026-08-28 | $0.00 derived: sum of 3 quarters · filed 2026-08-28 | $1.30M derived: sum of 4 quarters · filed 2026-08-28 | ||
| 2025-03-31 | $1.50M 10-Q/A · filed 2026-08-28 | $800.00K derived: sum of 2 quarters · filed 2026-08-28 | $2.10M derived: sum of 3 quarters · filed 2026-08-28 | $2.50M derived: sum of 4 quarters · filed 2026-08-28 | ||
| 2024-12-31 | -$700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $600.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.00M derived: sum of 3 quarters · filed 2026-02-26 | $1.50M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.70M derived: sum of 2 quarters · filed 2025-10-29 | $2.20M 10-Q · filed 2025-10-29 | $1.60M derived: sum of 4 quarters · filed 2025-10-29 | ||
| 2024-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $900.00K 10-Q · filed 2025-07-31 | $300.00K derived: sum of 3 quarters · filed 2025-07-31 | $6.20M derived: sum of 4 quarters · filed 2025-07-31 | ||
| 2024-03-31 | $500.00K 10-Q · filed 2025-05-01 | -$100.00K derived: sum of 2 quarters · filed 2025-05-01 | $5.80M derived: sum of 3 quarters · filed 2025-05-01 | $14.90M derived: sum of 4 quarters · filed 2025-05-01 | ||
| 2023-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $5.30M derived: sum of 2 quarters · filed 2025-03-03 | $14.40M derived: sum of 3 quarters · filed 2025-03-03 | $19.20M 10-K · filed 2025-03-03 | ||
| 2023-09-30 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $15.00M derived: sum of 2 quarters · filed 2024-11-07 | $19.80M 10-Q · filed 2024-11-07 | $13.50M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $9.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $13.90M 10-Q · filed 2024-08-07 | $7.60M derived: sum of 3 quarters · filed 2024-08-07 | $14.20M derived: sum of 4 quarters · filed 2024-08-07 | ||
| 2023-03-31 | $4.80M 10-Q · filed 2024-05-07 | -$1.50M derived: sum of 2 quarters · filed 2024-05-07 | $5.10M derived: sum of 3 quarters · filed 2024-05-07 | $23.10M derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | -$6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $300.00K derived: sum of 2 quarters · filed 2024-03-01 | $18.30M derived: sum of 3 quarters · filed 2024-03-01 | $21.50M 10-K · filed 2024-03-01 | ||
| 2022-09-30 | $6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $24.60M derived: sum of 2 quarters · filed 2023-11-06 | $27.80M 10-Q · filed 2023-11-06 | $32.20M derived: sum of 4 quarters · filed 2023-11-06 | ||
| 2022-06-30 | $18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $21.20M 10-Q · filed 2023-08-03 | $25.60M derived: sum of 3 quarters · filed 2023-08-03 | $33.10M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $3.20M 10-Q · filed 2023-05-03 | $2.00M 10-Q · filed 2022-05-09 | $7.60M derived: sum of 2 quarters · filed 2023-05-03 | $15.10M derived: sum of 3 quarters · filed 2023-05-03 | $15.60M derived: sum of 4 quarters · filed 2023-05-03 | |
| 2021-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $11.90M derived: sum of 2 quarters · filed 2023-02-27 | $12.40M derived: sum of 3 quarters · filed 2023-02-27 | $40.40M 10-K · filed 2023-02-27 | ||
| 2021-09-30 | $7.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $8.00M derived: sum of 2 quarters · filed 2022-11-08 | $36.00M 10-Q · filed 2022-11-08 | $34.70M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $28.50M 10-Q · filed 2022-08-04 | $27.20M derived: sum of 3 quarters · filed 2023-02-27 | $28.60M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-03-31 | $28.00M 10-Q · filed 2022-05-09 | $26.70M derived: sum of 2 quarters · filed 2023-02-27 | $28.10M derived: sum of 3 quarters · filed 2023-02-27 | $19.40M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2020-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $100.00K derived: sum of 2 quarters · filed 2023-02-27 | -$8.60M derived: sum of 3 quarters · filed 2023-02-27 | $300.00K 10-K · filed 2023-02-27 | ||
| 2020-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$7.30M derived: sum of 2 quarters · filed 2021-10-28 | $1.60M 10-Q · filed 2021-10-28 | $600.00K derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | -$8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $200.00K 10-Q · filed 2021-07-29 | -$800.00K derived: sum of 3 quarters · filed 2022-03-01 | $39.30M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $8.90M 10-Q · filed 2021-04-28 | $7.90M derived: sum of 2 quarters · filed 2022-03-01 | $48.00M derived: sum of 3 quarters · filed 2022-03-01 | $25.30M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $39.10M derived: sum of 2 quarters · filed 2022-03-01 | $16.40M derived: sum of 3 quarters · filed 2022-03-01 | $24.80M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $40.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $17.40M derived: sum of 2 quarters · filed 2020-10-29 | $25.80M 10-Q · filed 2020-10-29 | $25.20M derived: sum of 4 quarters · filed 2021-02-18 | ||
| 2019-06-30 | -$22.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$14.30M 10-Q · filed 2020-07-31 | $14.30M 10-Q · filed 2019-08-07 | -$14.90M derived: sum of 3 quarters · filed 2021-02-18 | -$7.20M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-03-31 | $8.40M 10-Q · filed 2020-05-06 | $7.80M derived: sum of 2 quarters · filed 2021-02-18 | $15.50M derived: sum of 3 quarters · filed 2021-02-18 | $15.50M derived: sum of 4 quarters · filed 2021-02-18 | ||
| 2018-12-31 | -$600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $7.10M derived: sum of 2 quarters · filed 2021-02-18 | $7.10M derived: sum of 3 quarters · filed 2021-02-18 | $22.80M 10-K · filed 2021-02-18 | ||
| 2018-09-30 | $7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $7.70M derived: sum of 2 quarters · filed 2019-11-05 | $23.40M 10-Q · filed 2019-11-05 | $58.70M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $15.70M 10-Q · filed 2019-08-07 | $51.00M derived: sum of 3 quarters · filed 2020-03-02 | |||
| 2018-03-31 | $15.70M 10-Q · filed 2019-05-08 | $51.00M derived: sum of 2 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $35.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $66.00M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $30.70M 10-Q · filed 2018-11-09 | |||||
| 2016-12-31 | $0.00 8-K · filed 2019-01-29 | |||||
| 2015-12-31 | $0.00 8-K · filed 2019-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |